Synopsis: An infrastructure EPC player reported consolidated revenue of Rs. 5,368 crore and PAT of Rs. 832 crore in FY26, while Q4 profit jumped 44 percent YoY to Rs. 108 crore aided by HAM asset monetization gains. Following the complete exit from toll assets, the...
Synopsis:A Gujarat-based fertilizer and chemicals maker posted a sharp jump in quarterly profit, backed by better product prices and falling input costs, while pushing ahead with a multi-thousand crore expansion plan. A Gujarat-based integrated chemicals and...
Synopsis:-Grasim Industries posted its highest-ever quarterly consolidated revenue of Rs. 51,101 crore and record EBITDA of Rs. 8,011 crore in Q4FY26, with every major business segment cement, cellulosic fibres, chemicals, paints, and financial services reporting...
Synopsis: IRB Infrastructure reported a stable Q4 FY26 performance with growth in profitability supported by improved operational efficiency and higher contributions from InvIT-related assets. The company posted quarterly revenue of Rs. 1,927 crore and net profit of...
Synopsis: KDDL Limited reported strong FY26 revenue growth driven by its watch component businesses, while the company remains optimistic about future growth across bracelets, precision engineering, packaging, and Swiss manufacturing segments. This Small-Cap Stock,...
Synopsis:- Reporting its audited results for Q4 FY26 and the full financial year ended March 31, 2026, Zee Entertainment Enterprises Limited posted a sharp decline in consolidated profitability as a weak advertising environment and elevated content costs weighed on...
Synopsis:-Posting its strongest annual performance on record, a precision plastics manufacturer reported FY26 consolidated revenue of Rs.990.7 crore and net profit of Rs.169.9 crore, up 83 percent year-on-year, driven by a sharp surge in healthcare and drug-delivery...
Synopsis: Mahindra EPC Irrigation Limited is capturing major market attention today, Wednesday, May 20, 2026, after securing a fresh domestic community micro-irrigation contract. Investors are closely tracking the Mahindra Group subsidiary as its spectacular FY26...
Synopsis:- Mankind Pharma reported FY26 consolidated revenue of Rs. 14,278 crore a 17 percent increase year-on-year with Q4 adjusted EBITDA margins touching 27.1 percent and net debt-to-EBITDA declining to a comfortable 1.1x, as the BSV acquisition delivered visible...
Synopsis: RITES Limited continued to see steady business momentum in FY26, supported by strong execution, rising exports, healthy order inflows, and a record order book that improves future growth visibility. The shares of this small-cap company majorly engaged in the...
